DK2257810T3 - Molekylær diagnose og klassificering af malignt melanom - Google Patents
Molekylær diagnose og klassificering af malignt melanomInfo
- Publication number
- DK2257810T3 DK2257810T3 DK09718437.8T DK09718437T DK2257810T3 DK 2257810 T3 DK2257810 T3 DK 2257810T3 DK 09718437 T DK09718437 T DK 09718437T DK 2257810 T3 DK2257810 T3 DK 2257810T3
- Authority
- DK
- Denmark
- Prior art keywords
- maligned
- melanoma
- classification
- molecular diagnosis
- diagnosis
- Prior art date
Links
- 238000003745 diagnosis Methods 0.000 title 1
- 201000001441 melanoma Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3410908P | 2008-03-05 | 2008-03-05 | |
| PCT/US2009/036227 WO2009111661A1 (en) | 2008-03-05 | 2009-03-05 | Molecular diagnosis and classification of malignant melanoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2257810T3 true DK2257810T3 (da) | 2013-07-15 |
Family
ID=41056372
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK12177684.3T DK2518509T3 (da) | 2008-03-05 | 2009-03-05 | Molekylær prognose og klassificering af malignt melanom på basis af markører fra listen RGS1, NCOA3, SPP1, PHIP |
| DK09718437.8T DK2257810T3 (da) | 2008-03-05 | 2009-03-05 | Molekylær diagnose og klassificering af malignt melanom |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK12177684.3T DK2518509T3 (da) | 2008-03-05 | 2009-03-05 | Molekylær prognose og klassificering af malignt melanom på basis af markører fra listen RGS1, NCOA3, SPP1, PHIP |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US8492102B2 (da) |
| EP (2) | EP2518509B1 (da) |
| CN (1) | CN102037361A (da) |
| AU (1) | AU2009221778A1 (da) |
| CA (1) | CA2716357A1 (da) |
| DK (2) | DK2518509T3 (da) |
| ES (2) | ES2489840T3 (da) |
| NZ (1) | NZ587750A (da) |
| PT (2) | PT2257810E (da) |
| WO (1) | WO2009111661A1 (da) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2257810E (pt) | 2008-03-05 | 2013-08-22 | Univ California | Diagnóstico molecular e classificação de melanoma maligno |
| EP2626437A3 (en) | 2008-05-14 | 2013-12-11 | Dermtech International | Diagnosis of melanoma and solar lentigo by nucleic acid analysis |
| BR112012026837B1 (pt) * | 2010-04-20 | 2020-04-07 | Univ Cornell | método in vitro e kit para diagnosticar proliferações melanocíticas |
| CN102998448A (zh) * | 2011-09-09 | 2013-03-27 | 上海市计划生育科学研究所 | 来源于前列腺分泌液中的前列腺癌标记物 |
| WO2014077915A1 (en) | 2012-11-14 | 2014-05-22 | Mayo Foundation For Medical Education And Research | Methods and materials for identifying malignant skin lesions |
| BR112015022977B1 (pt) | 2013-03-14 | 2022-06-21 | Castle Biosciences, Inc | Métodos para predição de risco de metástase em melanoma cutâneo |
| CA2906523A1 (en) | 2013-03-15 | 2014-09-25 | Myriad Genetics, Inc. | Genes and gene signatures for diagnosis and treatment of melanoma |
| CN103472234B (zh) * | 2013-07-05 | 2015-01-07 | 武汉三鹰生物技术有限公司 | 一种酶联免疫检测及制备方法 |
| WO2016179043A1 (en) | 2015-05-01 | 2016-11-10 | Dermtech, Inc. | Non-invasive skin collection system |
| EP4250299A3 (en) | 2014-07-02 | 2023-12-06 | Myriad myPath, LLC | Genes and gene signatures for diagnosis and treatment of melanoma |
| WO2016025717A1 (en) | 2014-08-14 | 2016-02-18 | Mayo Foundation For Medical Education And Research | Methods and materials for identifying metastatic malignant skin lesions and treating skin cancer |
| EP3455761B1 (en) | 2016-05-10 | 2021-12-22 | Mayo Foundation for Medical Education and Research | Methods and materials for staging and treating skin cancer |
| EP3752645A4 (en) | 2018-02-14 | 2022-04-13 | Dermtech, Inc. | Novel gene classifiers and uses thereof in non-melanoma skin cancers |
| AU2019310636B2 (en) | 2018-07-25 | 2025-06-26 | Mayo Foundation For Medical Education And Research | Gene signatures for predicting metastasis of melanoma and patient prognosis |
| JP2022524641A (ja) | 2019-03-26 | 2022-05-09 | ダームテック，インク． | 皮膚癌における新規な遺伝子分類子とその使用 |
| CN110438229A (zh) * | 2019-08-01 | 2019-11-12 | 上海交通大学 | 一种胃癌预后诊断生物标记物及其诊断试剂盒 |
| CN113362884A (zh) * | 2020-03-06 | 2021-09-07 | 福建和瑞基因科技有限公司 | 基于单碱基替换特征的肿瘤标志物筛选方法及应用 |
| EP4146677A4 (en) * | 2020-05-04 | 2025-01-15 | Mayo Foundation for Medical Education and Research | Detecting melanoma |
| CN113293214A (zh) * | 2021-06-17 | 2021-08-24 | 深圳华因康基因科技有限公司 | 一种检测神经母细胞瘤复发转移基因wnt2扩增的引物探针及其应用 |
| CN115786504B (zh) * | 2022-08-31 | 2023-09-19 | 中国人民解放军总医院京南医疗区 | Hspa4抑制剂在治疗黑素瘤中的应用 |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1283014B (de) | 1963-03-05 | 1968-11-14 | Tokyo Yuki Kagaku Kogyo Kabush | Fungizid, bakterizid, insektizid und nematozid wirkende Pflanzenschutzmittel |
| US3366308A (en) | 1966-04-11 | 1968-01-30 | Archer Products Inc | Collapsible container |
| US4452720A (en) | 1980-06-04 | 1984-06-05 | Teijin Limited | Fluorescent composition having the ability to change wavelengths of light, shaped article of said composition as a light wavelength converting element and device for converting optical energy to electrical energy using said element |
| US4439356A (en) | 1981-03-03 | 1984-03-27 | Syva Company | Unsymmetrical fluorescein derivatives |
| US5506337A (en) | 1985-03-15 | 1996-04-09 | Antivirals Inc. | Morpholino-subunit combinatorial library and method |
| US4987071A (en) | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
| US5330900A (en) | 1987-12-31 | 1994-07-19 | Tropix, Inc. | Chemiluminescent 3-(substituted adamant-2'-ylidene) 1,2-dioxetanes |
| US5010175A (en) | 1988-05-02 | 1991-04-23 | The Regents Of The University Of California | General method for producing and selecting peptides with specific properties |
| US5066580A (en) | 1988-08-31 | 1991-11-19 | Becton Dickinson And Company | Xanthene dyes that emit to the red of fluorescein |
| US5227487A (en) | 1990-04-16 | 1993-07-13 | Molecular Probes, Inc. | Certain tricyclic and pentacyclic-hetero nitrogen rhodol dyes |
| IE66205B1 (en) | 1990-06-14 | 1995-12-13 | Paul A Bartlett | Polypeptide analogs |
| US5650489A (en) | 1990-07-02 | 1997-07-22 | The Arizona Board Of Regents | Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| US5750409A (en) | 1991-11-18 | 1998-05-12 | Boehringer Mannheim Gmbh | Pentacyclic compounds and their use as absorption or fluorescent dyes |
| US5573905A (en) | 1992-03-30 | 1996-11-12 | The Scripps Research Institute | Encoded combinatorial chemical libraries |
| US5885527A (en) | 1992-05-21 | 1999-03-23 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membrances |
| US5288514A (en) | 1992-09-14 | 1994-02-22 | The Regents Of The University Of California | Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support |
| US5519134A (en) | 1994-01-11 | 1996-05-21 | Isis Pharmaceuticals, Inc. | Pyrrolidine-containing monomers and oligomers |
| US5593853A (en) | 1994-02-09 | 1997-01-14 | Martek Corporation | Generation and screening of synthetic drug libraries |
| US5539083A (en) | 1994-02-23 | 1996-07-23 | Isis Pharmaceuticals, Inc. | Peptide nucleic acid combinatorial libraries and improved methods of synthesis |
| US6447796B1 (en) | 1994-05-16 | 2002-09-10 | The United States Of America As Represented By The Secretary Of The Army | Sustained release hydrophobic bioactive PLGA microspheres |
| US5525735A (en) | 1994-06-22 | 1996-06-11 | Affymax Technologies Nv | Methods for synthesizing diverse collections of pyrrolidine compounds |
| US5549974A (en) | 1994-06-23 | 1996-08-27 | Affymax Technologies Nv | Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof |
| US5569588A (en) | 1995-08-09 | 1996-10-29 | The Regents Of The University Of California | Methods for drug screening |
| US5847162A (en) | 1996-06-27 | 1998-12-08 | The Perkin Elmer Corporation | 4, 7-Dichlororhodamine dyes |
| US6080852A (en) | 1996-06-27 | 2000-06-27 | The Perkin-Elmer Corporation | 4,7-dichlororhodamine dyes |
| US6008379A (en) | 1997-10-01 | 1999-12-28 | The Perkin-Elmer Corporation | Aromatic-substituted xanthene dyes |
| US5936087A (en) | 1997-11-25 | 1999-08-10 | The Perkin-Elmer Corporation | Dibenzorhodamine dyes |
| CA2365625A1 (en) | 1999-03-10 | 2000-09-14 | Phogen Limited | Delivery of substances to cells |
| US20020155440A1 (en) * | 2000-12-19 | 2002-10-24 | Ljubimova Julia Y. | Using overexpression of laminin alpha 4 subunit as a diagnostic and prognostic indicator of malignant tumors |
| US20020130430A1 (en) | 2000-12-29 | 2002-09-19 | Castor Trevor Percival | Methods for making polymer microspheres/nanospheres and encapsulating therapeutic proteins and other products |
| US7247426B2 (en) * | 2001-08-02 | 2007-07-24 | Agilent Technologies, Inc. | Classifying cancers |
| US7060498B1 (en) | 2001-11-28 | 2006-06-13 | Genta Salus Llc | Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
| US7141540B2 (en) | 2001-11-30 | 2006-11-28 | Genta Salus Llc | Cyclodextrin grafted biocompatible amphilphilic polymer and methods of preparation and use thereof |
| US20050222064A1 (en) | 2002-02-20 | 2005-10-06 | Sirna Therapeutics, Inc. | Polycationic compositions for cellular delivery of polynucleotides |
| EP1585756B1 (en) | 2002-11-26 | 2010-04-21 | University of Massachusetts | Delivery of sirnas |
| CN1906308B (zh) | 2003-12-19 | 2011-09-14 | 诺华疫苗和诊断公司 | 小干扰rna的细胞转染制剂、相关组合物以及制备和使用方法 |
| EP2145957B1 (en) | 2004-04-20 | 2013-12-25 | Marina Biotech, Inc. | Compositions for enhancing delivery of double-stranded RNA to regulate gene expression in mammalian cells |
| US7514530B2 (en) | 2004-04-26 | 2009-04-07 | Centre National De La Recherche Scientifique | Peptide carrier for delivering siRNA into mammalian cells |
| US20110159496A1 (en) * | 2006-09-06 | 2011-06-30 | The Regents Of The University Of California | Molecular diagnosis and classification of malignant melanoma |
| US7615349B2 (en) * | 2006-09-07 | 2009-11-10 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Melanoma gene signature |
| PT2257810E (pt) | 2008-03-05 | 2013-08-22 | Univ California | Diagnóstico molecular e classificação de melanoma maligno |
-
2009
- 2009-03-05 PT PT97184378T patent/PT2257810E/pt unknown
- 2009-03-05 US US12/920,957 patent/US8492102B2/en not_active Expired - Fee Related
- 2009-03-05 NZ NZ587750A patent/NZ587750A/xx not_active IP Right Cessation
- 2009-03-05 EP EP12177684.3A patent/EP2518509B1/en active Active
- 2009-03-05 ES ES12177684.3T patent/ES2489840T3/es active Active
- 2009-03-05 DK DK12177684.3T patent/DK2518509T3/da active
- 2009-03-05 ES ES09718437T patent/ES2424329T3/es active Active
- 2009-03-05 AU AU2009221778A patent/AU2009221778A1/en not_active Abandoned
- 2009-03-05 EP EP09718437.8A patent/EP2257810B1/en active Active
- 2009-03-05 PT PT121776843T patent/PT2518509E/pt unknown
- 2009-03-05 DK DK09718437.8T patent/DK2257810T3/da active
- 2009-03-05 WO PCT/US2009/036227 patent/WO2009111661A1/en not_active Ceased
- 2009-03-05 CN CN2009801161582A patent/CN102037361A/zh active Pending
- 2009-03-05 CA CA2716357A patent/CA2716357A1/en not_active Abandoned
-
2013
- 2013-06-18 US US13/920,963 patent/US20130344481A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN102037361A (zh) | 2011-04-27 |
| DK2518509T3 (da) | 2014-08-18 |
| CA2716357A1 (en) | 2009-09-11 |
| PT2257810E (pt) | 2013-08-22 |
| WO2009111661A9 (en) | 2010-06-10 |
| EP2257810A4 (en) | 2011-06-08 |
| US20110123997A1 (en) | 2011-05-26 |
| EP2518509A3 (en) | 2013-01-23 |
| NZ587750A (en) | 2012-10-26 |
| ES2489840T3 (es) | 2014-09-02 |
| ES2424329T3 (es) | 2013-10-01 |
| AU2009221778A1 (en) | 2009-09-11 |
| EP2257810A1 (en) | 2010-12-08 |
| EP2257810B1 (en) | 2013-06-05 |
| EP2518509A2 (en) | 2012-10-31 |
| PT2518509E (pt) | 2014-09-01 |
| US8492102B2 (en) | 2013-07-23 |
| EP2518509B1 (en) | 2014-05-14 |
| US20130344481A1 (en) | 2013-12-26 |
| WO2009111661A1 (en) | 2009-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2257810T3 (da) | Molekylær diagnose og klassificering af malignt melanom | |
| DK2062049T3 (da) | Molekulær diagnose og klassificering af malignt melanoma | |
| BRPI0912379A2 (pt) | dspositivo de compressão de artéria radial | |
| BRPI0908578A2 (pt) | Ensaios de atividades de sorotipo a de toxina botulínica imunobaseada | |
| EP2278920A4 (en) | Fitness test | |
| EP2260108A4 (en) | PROTEASE ASSAY | |
| DK2310356T3 (da) | Adamantyl-diamid-derivater og anvendelser deraf | |
| EP2298731A4 (en) | AMIDE COMPOUND | |
| DE502008001391D1 (de) | Heteroaroylsubstituierte serin-amide | |
| DK3514519T3 (da) | Testkassetter | |
| BRPI0822064A2 (pt) | Dispositivos de imageamento fotoacústico e métodos de imageamento | |
| EP2293092A4 (en) | MAGNETIC SENSOR ELEMENT IMPEDANCE | |
| EP2347531A4 (en) | TEST BY AIR | |
| AT506816B1 (de) | Vlf-prüfgenerator | |
| EP2467169A4 (en) | IN VIVO SCREENING ASSAYS | |
| DK2614832T3 (da) | Diagnose og behandling af præeklampsi | |
| BRPI0816363A2 (pt) | Biossensor e medidor de leitura | |
| EP2356425A4 (en) | PORTABLE POLYMER TESTER | |
| AT10812U2 (de) | Prüfstandsanordnung | |
| AT10813U2 (de) | Prüfstandsanordnung | |
| BRPI0917985A2 (pt) | conexão umbilical de campo | |
| DK2805746T3 (da) | Alkylamido-forbindelser og anvendelser deraf | |
| EP2128630A4 (en) | Probe card | |
| IT1395561B1 (it) | Apparato di collaudo e relativo procedimento | |
| DK2347267T3 (da) | Testbåndenhed og testbåndindretning |